AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
195.15
0.00 (0.00%)
At close: Jul 2, 2026, 4:00 PM EDT
190.31
-4.84 (-2.48%)
Pre-market: Jul 6, 2026, 7:25 AM EDT

AstraZeneca Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Strong Buy" and an average price target of $224.29. The average 1-year stock price forecast is 14.93% higher than the current stock price, while the lowest is $184 (-5.71%) and the highest is $245 (+25.54%).

Price Target: $224.29 (+14.93%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$184$224.29$226.45$245
Change-5.71%+14.93%+16.04%+25.54%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy667777
Buy222222
Hold011111
Sell100000
Strong Sell000000
Total9910101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Buy
Maintains
$219$217
BuyMaintains$219$217+11.20%Jul 1, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$219
BuyReiterates$219+12.34%Jun 30, 2026
Deutsche Bank
Deutsche Bank
Sell
Maintains
$153
SellMaintains$153-21.71%Jun 30, 2026
Barclays
Barclays
Buy
Maintains
$219
BuyMaintains$219+12.34%Jun 30, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$213
BuyMaintains$213+8.93%Jun 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
63.33B
from 58.74B
Increased by 7.82%
Revenue Next Year
67.02B
from 63.33B
Increased by 5.83%
EPS This Year
10.30
from 9.16
Increased by 12.42%
EPS Next Year
11.56
from 10.30
Increased by 12.25%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
37.42B44.35B45.81B54.07B58.74B63.33B
Revenue Growth
40.58%18.53%3.29%18.04%8.63%7.82%
Gross Profit
25.41B35.71B37.77B44.44B47.99B52.40B
Gross Margin
67.92%80.52%82.44%82.18%81.71%82.75%
Operating Income
2.90B8.81B9.70B12.93B14.29B21.23B
Net Income
112.00M3.29B5.96B7.04B10.23B12.47B
EPS
----9.1610.30
EPS Growth
----11.57%12.42%
Forward PE
-----18.95
Dividend / Share
2.872.902.903.103.203.33
Dividend Growth
-1.05%-6.90%3.23%4.21%
Free Cash Flow
-1.85B12.49B9.04B8.46B7.87B10.04B
No. Analysts
-----24
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High64.8B
Avg63.3B
Low58.6B

Revenue Growth

Revenue Growth202620272028
High
10.4%
Avg
7.8%
Low
-0.2%

EPS Forecast

EPS202620272028
High10.74
Avg10.30
Low10.07

EPS Growth

EPS Growth202620272028
High
17.2%
Avg
12.4%
Low
9.9%